Jump to content

Genedata Releases New Request Management System for Biotherapeutics R&D Processes

Request and task management software increases operational efficiency of biopharma R&D organizations

February 12, 2019
Basel, Switzerland

Genedata, a leading provider of advanced software solutions for biopharmaceutical R&D, today announced the release of a new Request Management Module, which improves operational efficiency and monitors overall R&D operations by supporting the full life cycle of task scheduling. Used to submit and track requests from initiation through completion, it manages intergroup communications and centrally documents project progression in real time. The module addresses key operational requirements, such as scheduling complex, iterative, multi-step tasks, and provides status updates of each task to ensure all steps are completed on time. The software is particularly valuable for biopharma R&D operations in a division-of-labor environment in which completion of experiments not only requires close interactions between specialized groups, such as molecular biology, expression, purification, analytics, and assay teams, but also the integration of tasks performed by CROs and other external collaborators. The module is part of the continuously growing Genedata Biopharma Platform and is available for immediate licensing.

The new Request Management Module is the result of long-term co-development collaborations with major biopharmaceutical partners, where it has been implemented and is already being successfully used, for example, to streamline the production and characterization of both therapeutic antibodies and novel bispecific and other next-generation biologics. It has three main advantages over generic or custom-built request management systems. First, it comes with built-in business logic tailored to biopharma R&D workflows. Second, it is an off-the-shelf system that can be put into productive use immediately after installation, and can also be flexibly configured to support customer-specific process requirements. Finally, it seamlessly integrates with the biopharmaceutical workflows systems Genedata Biologics® and Genedata Bioprocess® for large-molecule discovery and development. Integrations with other systems in the Genedata Biopharma Platform are under development.

“Our new Request Management Module is another major step towards building a fully integrated end-to-end platform for biotherapeutics research, development, and manufacturing,” stated Dr. Othmar Pfannes, CEO of Genedata. “This new system complements our existing biopharma platform solutions and further optimizes resource allocation, increases productivity, and generates significant efficiencies for our customers.”

About Genedata

Genedata transforms data into intelligence with innovative software solutions that incorporate extensive biopharma R&D domain knowledge. Multinational biopharmaceutical organizations and cutting-edge biotechs around the globe rely on Genedata to digitalize and automate data-rich and complex R&D processes. From early discovery all the way to the clinic, Genedata solutions help maximize the ROI in R&D expenditure. Founded in 1997, Genedata is headquartered in Basel, Switzerland with additional offices in Boston, London, Munich, San Francisco, Singapore, and Tokyo.
LinkedIn | Twitter | YouTube


Allison Kurz
Public Relations


The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

Our new Request Management Module is another major step towards building a fully integrated end-to-end platform for biotherapeutics research, development, and manufacturing